Clinical Trial Update: A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2, placebo-controlled trial evaluating PF-00489791 in patients with type 2 diabetes and overt nephropathy has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus with Nephropathy

Drugs mentioned

• PF-00489791 (PF-00489791)

Snippet

Sponsor: Pfizer | Conditions: Diabetic Nephropathies | Phase 2 | Status: COMPLETED | Results posted: 2019-03-12